The Enterprise Value as of December 2025 (TTM) for Nymox Pharmaceutical Corporation (NYMX) is 6.26M

According to Nymox Pharmaceutical Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 6.26M. This represents a change of -78.49% compared to the average of 29.11M of the last 4 quarters.

Nymox Pharmaceutical Corporation (NYMX) Historical Enterprise Value (quarterly & annually)

How has NYMX Enterprise Value performed in the past?

The mean historical Enterprise Value of Nymox Pharmaceutical Corporation over the last ten years is 98.00M. The current 6.26M Enterprise Value has changed 538.78% with respect to the historical average. Over the past ten years (40 quarters), NYMX's Enterprise Value was at its highest in in the September 2021 quarter at 169.83M. The Enterprise Value was at its lowest in in the December 2024 quarter at 9.35M.

Nymox Pharmaceutical Corporation (NYMX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nymox Pharmaceutical Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nymox Pharmaceutical Corporation (NYMX) Average Enterprise Value

How has NYMX Enterprise Value performed in the past?

The current Enterprise Value of Nymox Pharmaceutical Corporation (NYMX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nymox Pharmaceutical Corporation (NYMX) Enterprise Value vs. Peers

How is NYMX’s Enterprise Value compared to its peers?

Nymox Pharmaceutical Corporation’s Enterprise Value is greater than COSCIENS Biopharma Inc. (-425261.00), greater than Pieris Pharmaceuticals, Inc. (-52477736.00), greater than PHAXIAM Therapeutics S.A. (3.80M), less than MEI Pharma, Inc. (10.34M), greater than MetaVia Inc. (4.78M), greater than AlphaTON Capital Corp. (-25062.00), less than Kineta, Inc. (7.37M), greater than Traws Pharma, Inc. (-7003292.00), greater than Theriva Biologics, Inc. (-4433850.00), greater than Elevation Oncology, Inc. (-7613691.00),

Build a custom stock screener for Nymox Pharmaceutical Corporation (NYMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nymox Pharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nymox Pharmaceutical Corporation (NYMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nymox Pharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.